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The study was carried out to investigate the release profile of matrix (non-disintegrating) granules 
consisting of paracetamol (drug) and acrylatemethacrylate copolymer, a matrix forming material. The 
effect of coating the matrix granules with wax on the drug release profiles was also investigated. The 
objective was to produce drug particles of different release profiles for application as multi-unit dosage 
forms. The matrix granules were formed by massing paracetamol powder with a concentrated ethanolic 
solution of the acrylatemethacrylate copolymer (40%, w/v) followed by drying and screening. Wax 
coating was achieved by mixing the matrix granules with a melt of carnuba wax. Conventional granules 
of paracetamol were made by granulation with starch mucilage (20%, w/v); this served as reference 
samples for comparison. The granules were subjected to size analysis, packing/flow property, friability 
and dissolution tests. All the granules (i.e. conventional, matrix as well as the coated matrix granules) 
flowed readily and were also compressible upon tapping. The compressibility index values were 
conventional granules (39±2.2%), matrix granules (27±1.8%) and coated matrix granules (24±1.9%). The 
friability values were conventional granules (1.96±0.02), matrix granules (0.78±0.01) and coated matrix 
granules (0.63±0.03), indicating that matrix granulation increased the cohesive strength of the granules. 
The dissolution rates were conventional granules (16% h-1), matrix granules (9.4% h-1) and coated matrix 
granules (4.4% h-1). Thus, matrix granulation and wax coating of the matrix granules are approaches for 
retarding drug release and hence prolonging the biologic action of drugs with short biologic half live.  
 





In the past few decades, different types of oral controlled 
release (CR) formulations have been developed to 
improve the clinical efficacy of drugs and patient 
compliance (Dehaan and Lerk, 1984; Li and Lee, 1987). 
These formulations are designed to deliver drugs at a 
predetermined rate over a wide range of conditions and 
durations of therapeutic treatment. Matrix-based systems 
in which the drug is dispersed as a fine powder in a 
matrix of polymeric and/or non-polymeric material are 
choices for CR applications, mainly because they are 
easy to manufacture (Cardinal, 1984).  
Modifications in the release profiles are aimed at 
altering the onset, the rate of release from the dosage 
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be performed on oral as well as non-oral dosage forms to 
control the drug release. For an oral dosage form, 
modification of drug release can be achieved via control 
of mechanisms that include diffusion, erosion, osmosis, 
etc. Matrix and coated systems represent a major portion 
of the oral modified release dosage forms. CR systems 
are therefore invariably multi-unit dosage forms 
consisting of particles of different release profiles. The 
term matrix granulation refers here to the formation of 
non-disintegrating granules by wet massing the drug 
powder with concentrated gels of water-insoluble 
polymers. The resulting matrix granules do not 
disintegrate to their primary particles when agitated in 
aqueous fluids. Hence, matrix granulation is an approach 
for retarding drug release from the granules. Melt 
granulation of the matrix granules is achieved by mixing a 
drug powder/or granule with a melt of a wax material (e.g. 
carnuba wax or glyceryl monosterate) with the objective 






from the granules (Anurag et al., 2004). Dissolution of 
drug particles can also be similarly modified by film 
coating, but the operation is complex and expensive 
requiring initial spheronization and use of large volumes 
of expensive organic solvents during coating (Nastruzzi 
et al., 2000). 
In the present study therefore we have examined the 
effect of matrix granulation followed by melt granulation 








Carnuba wax (Halewood chemicals Ltd, England) is a fine waxy 
solid with melting point of 80 - 88°C, yellowish in colour. An 
acrylatemethacrylate copolymer was received under the trade name 
Eudragit RS100 as a gift from Rohm Gmbh (Darmstadt, Germany). It 
is water insoluble but dissolves slowly in ethanol. The polymer (in 
the form of gel) and maize starch BP (BDH, Poole, UK) were used 
as binders in the granulation of the drug powder. The test drug, 
paracetamol was a product of BDH (Poole, UK). Although sustained 
release formulations are usually applied to potent drugs with short 
biologic half-lives, paracetamol was selected because of its 





Paracetamol granules were formed by the convectional granulation 
technique using starch mucilage (20%, w/w) as binder and these 
were designated conventional granules. Matrix (i.e. non-
disintegrating) granules were formed by wet massing the drug 
powder with a concentrated (40%, w/v) ethanolic solution of the 
polymer. The ethanolic solution was of gel consistency. The 
cohesive mass was pressed through a mesh (1 mm pore size) and 
drying in a hot air oven (Kottermann, Germany) at 50°C for 1 h to a 
moisture content, 1.3±0.2% (w/w). Lower concentrations (<40%) of 
the polymer solution in ethanol formed granules that disintegrated 
to their primary particles in aqueous fluids which informed the use 
of 40% (w/v) polymer gel in the matrix granulation. The granules 
were stored in an airtight container for 24 h before their evaluation.  
 
 
Wax coating of the matrix granules 
 
The matrix granules were wax coated by mixing a sample of the 
matrix granules (40 g) with 10 g of the wax previously melted in a 
water bath at 90°C. During mixing the granules would acquire film 
coating of the wax. The mass was screened through a sieve of pore 




Physical characterization of the granules 
 
Particle size distribution: This was carried out by sieve analysis 
using test sieves ranging in pore size from 1.7 mm to 212 µm and 
shaking samples of the granules for 5 min with the Endicott sieve 
shaker (Endicott’s Ltd, UK). Fractions retained on each sieve were 
weighed to determine the size distribution.    




The Packing properties: These were determined by measuring 
the bulk density (BD) and tapped density (TB) using standard 
procedures (Richards, 1972). From the data compressibility index 
(CI) values of the granules were calculated as CI = {(TB-BD)/TB} × 
100% (Carr, 1965).  
 
Flowability: The flowability of the granules was determined by 
measuring the angle of repose formed when a sample of the 
granules (40 g) was allowed to fall freely from the stem of a funnel 
to a horizontal surface (Richards, 1972). 
 
Friability: Fines in the granules samples were first removed by 
shaking the samples (5 min) on a sieve of pore size 212 µm. A 
sample of the residual coarse granules (20 g) was placed in the 
drum of an Erweka friabulator (Heusenstamm, Germany) rotating at 
20 rev per min for 10 min. The % dust formed due to the impact 
was determined and taken as index of friability. The test was carried 






A sample of the granules (500 mg) was filled into a capsule shell 
and placed in a cylindrical basket (aperture size 425 µm, diameter 
20 mm; height 30 mm), which was immersed in 800 ml of leaching 
fluid (0.1 N hydrochloric acid maintained at 37 ± 2°C). The fluid was 
stirred at 100 rpm with a single blade GallenKamp stirrer (Model 
APP No 4B 5784A. Cat No: SS530). Samples (5 ml) were 
withdrawn from the leaching fluid at selected time intervals with a 
pipette fitted with a cotton wool plug, replacing with an equal 
volume of drug-free dissolution fluid. The samples were suitably 
diluted with blank dissolution fluid and were analysed for content of 
paracetamol spectrophotometrically at λ max, 245 nm (Model 
Spectronic 21D, Bausch and Lomb, USA). For coated matrix 
granules, the samples were kept in the fridge overnight to allow 
solidification of the wax which may have leached during the 
dissolution test. The samples were filtered before assay. The 
amounts released were expressed as a percentage of the initial 
amount of drug in the granule samples. The determination was 
carried out in triplicate and the mean results reported.  
 
 
RESULTS AND DISCUSSION 
 
Packing and flow properties 
 
The results (Table 1) showed the packing and flow 
properties of conventional, matrix and the coated matrix 
granules. All the granules exhibited satisfactory flowability 
as reflected by the low angles of repose (<20°). The 
results also showed that the granules were fairly 
compressible by tapping. CI values ranged from 24% 
(coated matrix) to 39% (conventional granules) 
attributable to the higher proportion of fines in the 
conventional granules. The fines will fill into intragranular 
spaces during tapping. 
 
 
Friability of the granules 
 
Matrix granulation imparted greater interparticulate 
cohesiveness   to   the   granules   compared    with    the  
 




Table 1. Physical properties of the granules. 
 
Parameters assessed Conventional Matrix Coated matrix 
Angle of repose (0°) 12.3±1.2 15.2±1.1 17.2±1.1 
Bulk density (g/cm3) 0.35±0.02 0.45±0.03 0.51±0.01 
Tapped density (g/cm3) 0.58±0.03 0.62±0.02 0.67±0.02 
Compressibility (Carr’s index) 39 ± 2.2 27±1.8 24±1.9 




conventional granulation. As can be seen in Table 1, the 
friability index values of the conventional granules was 
significantly higher than that of the matrix granules or the 
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Figure 1. Particle size distribution in the conventional 




Particle size distribution 
 
The data are plotted in Figure 1 (frequency/size curves). 
The particle size ranged from 212 to 1000 
µm(conventional granules) and 212 to 1700 µm (matrix 
granules). The most frequent size in the granules 
increased to 1000 µm (matrix granules) compared with 
conventional granules (850 µm). On the other hand the 
proportion of fines of size ≤ 212 µm was higher in the 
conventional (15%) compared with the matrix granules 
(5%). This observation is attributable to the stronger 
binder effect of the polymer gel used in the matrix 
granulation,   producing    larger    and    more    cohesive 
granules. Wax coating did not modify the size distribution 
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Figure 2. Drug release profiles of the ensembles of the different 





Release profiles of the conventional, matrix and the 
coated matrix granules  
 
The release profiles from conventional, matrix and coated 
matrix granules are shown in Figure 2. The matrix 
granules compared with the conventional granules 
displayed a slower drug release; the coated matrix 
granules in turn displayed a slightly slower release than 
the matrix (Table 2). Thus, matrix granulation imparted a 
retard release property to the granules. Wax coating of 
the granules will further retard the release. Whereas drug 
release from the conventional granules would be by rapid 
dissolution (i.e. surface erosion) the release from the 
matrix systems will be by slow diffusion via aqueous 
channels (Sandip et al., 2003). The wax coat in the 
coated matrix granules will only introduce another 
diffusion layer for drug transfer but  will also  hinder  influx 
of  the  aqueous  leaching   fluid   into   the   core   of   the  
granules, thus accounting for the greater retarded release 
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Figure 3. Release profiles of paracetamol from different fractions 
of the conventional (A) and the matrix granules (B), size fractions 
212µm (), 500µm () , 850µm (), 1.0mm (), 1.7mm ()., Note 




Table 2. Dissolution rates of the conventional, 
matrix and coated matrix granules of paracetamol. 
 
Type of granules Dissolution rate (% h-1) 
Conventional 16 
Matrix 9.4 




Table 3. Dissolution rates of the different size fractions of the 
conventional and matrix granules. 
 
Dissolution rates (% h-1) of the 
granules 
Particle size (µm) 
Conventional Matrix 
212 48.5 32 
500 31.7 19 
850 23.5 15.3 
1000 13.4 13.3 




Effect of particle size on drug release rate of the 
granules 
 
The % frequency of the different size fraction of the 
granule is presented in Figure 1. The release profile of 
the different size fractions for the conventional and the 
matrix granules are shown in Figure 3. It can be seen that  
 
 




the granule fraction with the smallest size displayed the 
highest release rate compared with the fraction with 
bigger size (Table 3). This finding relates to the larger 
specific surface area associated with the smaller size 
particles. The application of this finding is that the particle 






The study has shown that matrix granulation of drug 
powders with concentrated gels of a hydrophilic polymer 
and wax coating of such granules are approaches for 
retarding drug release, and hence a means of prolonging 
the action of drugs with short biologic half life. Also, the 
study showed that the particle size distribution of the 
granules can be predetermined to optimize the drug 
release profiles. These findings have applications in the 
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